Conrad Wai
CIK 1971702 · CEO, Counterpart Health · last filed 2026-05-28
Conrad Wai is a CEO, Counterpart Health who has filed 26 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing shows the insider sold $879.5K of CLOV on May 28, 2026. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $12.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$12.11M
1
26
-$1.62M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLOV | CEO, Counterpart Health | 2,559,970 | $4.73 | $12.11M | -$1.62M | 26 | 2026-05-28 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-28 | CLOV | Sell (S) | −220,426 | -$879.5K | EDGAR |
| 2026-04-16 | CLOV | Tax (F) | −23,463 | -$47.9K | EDGAR |
| 2026-04-03 | CLOV | Grant (A) | +267,766 | $0 | EDGAR |
| 2026-03-17 | CLOV | Tax (F) | −100,195 | -$198.4K | EDGAR |
| 2026-01-20 | CLOV | Tax (F) | −25,868 | -$72.7K | EDGAR |
| 2025-12-16 | CLOV | Tax (F) | −98,411 | -$265.7K | EDGAR |
| 2025-11-04 | CLOV | Tax (F) | −124,378 | -$439.1K | EDGAR |
| 2025-10-17 | CLOV | Tax (F) | −92,181 | -$258.1K | EDGAR |
| 2025-09-16 | CLOV | Tax (F) | −98,412 | -$301.1K | EDGAR |
| 2025-08-04 | CLOV | Tax (F) | −27,930 | -$80.7K | EDGAR |